Phase I dose-escalation (DE) trial of high-dose melphalan (M) with palifermin (P) for cytoprotection followed by autologous stem cell transplantation (ASCT) for myeloma (MM) patients with abnormal renal function (AbRF).

Phase I ◽

Cell Transplantation ◽

Dose Escalation ◽

High Dose ◽

High Dose Melphalan ◽

Abnormal Renal Function

Phase I dose-escalation trial of high-dose melphalan (M) with palifermin (P) for cytoprotection followed by autologous stem cell transplantation (ASCT) for myeloma (MM) patients with normal renal function (NRF).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.6543 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 6543-6543

Author(s):

M. H. Abidi ◽

N. Tageja ◽

Z. S. Al-Kadhimi ◽

J. Abrams ◽

S. Cronin ◽

...

Keyword(s):

Renal Function ◽

Stem Cell ◽

Phase I ◽

Cell Transplantation ◽

Dose Escalation ◽

Normal Renal Function ◽

High Dose ◽

Faculty Opinions recommendation of A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954995.793461388 ◽

2012 ◽

Author(s):

Nelson Chao

Keyword(s):

Multiple Myeloma ◽

Renal Function ◽

Stem Cell ◽

Phase I ◽

Dose Escalation ◽

Normal Renal Function ◽

High Dose ◽

A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2012.08.003 ◽

2013 ◽

Vol 19 (1) ◽

pp. 56-61 ◽

Cited By ~ 13

Author(s):

Muneer H. Abidi ◽

Rishi Agarwal ◽

Nishant Tageja ◽

Lois Ayash ◽

Abhinav Deol ◽

...

Keyword(s):

Multiple Myeloma ◽

Renal Function ◽

Stem Cell ◽

Phase I ◽

Dose Escalation ◽

Normal Renal Function ◽

High Dose ◽

A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma

Bone Marrow Transplantation ◽

10.1038/s41409-019-0534-0 ◽

2019 ◽

Vol 54 (11) ◽

pp. 1881-1891

Author(s):

Noa Biran ◽

Scott D. Rowley ◽

David H. Vesole ◽

Shijia Zhang ◽

Michele L. Donato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Cell Transplantation ◽

Conditioning Regimen ◽

High Dose ◽

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

Leukemia ◽

10.1038/leu.2015.54 ◽

2015 ◽

Vol 29 (9) ◽

pp. 1945-1948 ◽

Cited By ~ 10

Author(s):

N Shah ◽

P F Thall ◽

P S Fox ◽

Q Bashir ◽

J J Shah ◽

...

Keyword(s):

Stem Cell ◽

Phase I ◽

Cell Transplantation ◽

High Dose ◽

High Dose Melphalan ◽

Relapsed Myeloma

Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma

Journal of Chemotherapy ◽

10.1179/1973947812y.0000000004 ◽

2012 ◽

Vol 24 (3) ◽

pp. 167-172 ◽

Cited By ~ 5

Author(s):

Muneer H Abidi ◽

Zartash Gul ◽

Judith Abrams ◽

Lois Ayash ◽

Abhinav Deol ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Cell Transplantation ◽

Phase I Trial ◽

Maintenance Phase ◽

High Dose ◽

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Leukemia Research ◽

10.1016/j.leukres.2006.09.021 ◽

2007 ◽

Vol 31 (8) ◽

pp. 1069-1075 ◽

Cited By ~ 18

Author(s):

Don M. Benson ◽

Patrick J. Elder ◽

Thomas S. Lin ◽

William Blum ◽

Sam Penza ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

High Dose Melphalan and Autologous Stem Cell Transplantation (Hdm/Sct) for Treatment of Al Amyloidosis

Amyloid and Amyloidosis ◽

10.1201/9781420037494.ch54 ◽

2004 ◽

pp. 160-162

Author(s):

D Wright ◽

V Sanchorawala ◽

R Falk ◽

J Berk ◽

J Anderson ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

Al Amyloidosis ◽

Renal function after tandem high-dose chemotherapy and autologous stem cell transplantation in children with Wilms tumor

Pediatric Transplantation ◽

10.1111/j.1399-3046.2011.01594.x ◽

2011 ◽

Vol 15 (8) ◽

pp. 855-860 ◽

Cited By ~ 2

Author(s):

Soo Hyun Lee ◽

Kyung Hoon Paik ◽

Ki Woong Sung ◽

Meong Hi Son ◽

Keon Hee Yoo ◽

...

Keyword(s):

Renal Function ◽

Stem Cell ◽

Cell Transplantation ◽

Wilms Tumor ◽

High Dose Chemotherapy ◽

High Dose

Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1783448 ◽

2020 ◽

Vol 61 (11) ◽

pp. 2714-2721

Author(s):

Ga-Young Song ◽

Sung-Hoon Jung ◽

Je-Jung Lee ◽

Jin Seok Kim ◽

Chang-Ki Min ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Propensity Score ◽

Cell Transplantation ◽

Conditioning Regimen ◽

High Dose ◽